Fundraising FoxSan Francisco · Seed · 6 people tracked
Also known as Bioverge Funds · Volumetric
Find your way into Bioverge
Sign up to see every warm intro you have to Bioverge
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bioverge team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
Bioverge is a venture fund manager based in San Francisco. SEC filings show 3 venture funds on record, most recently SU Fund I, a series of Bioverge Funds, LP ($122K offering) filed October 2019.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 6 people
from public directories
What they invest in
from 7 of 8 portfolio companiesBiotech ×7Medical Devices ×5Healthtech ×4Deep Tech ×3Digital Health ×3AI & Machine Learning ×2Mental Health ×1
HQs:United States×6United Kingdom×1
Investments · 8 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12 dated
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)inAdam Savitz(Executive Officer)inMichael Hanley(Executive Officer)Nicholas Smith(Chief Financial Officer and Chief Business Officer)inAaron Weaver(Director)Po Yu (Jeff) Chen(Director)
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesKorify CapitalMana Ventures+11 more
Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)inDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)
Co-investorsARCH Venture PartnersLifeforce CapitalOrbiMedDomain AssociatesEDB InvestmentsSection 32+9 more
Developing microscale robots to deliver therapies locally to targeted brain disease areas.
Co-investorsAlumni VenturesBlue Ivy VenturesBold Capital PartnersCompoundDeep InsightDolby Family Ventures+9 more
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
Co-investors20/20 HealthCare Partners LLCDolby Family VenturesFlucas VenturesTachyon VenturesVU Venture PartnersAmgen Ventures+1 more
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)
Co-investorsCantos VenturesHAWKTAILInitialized CapitalLifespan Vision VenturesMana VenturesSpacecadet Ventures+2 more
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
BiotechHealthtechMedical DevicesSan Francisco, US
Matthew De Silva(CEO)inPete Quinzio(Founder)inConnor Warnock(Senior Engineer)Van Duesterberg(Science Consultant)Omid Karkouti(Vice President of Business Development)Scott Patterson(Vice President of Engineering)
Co-investors11.2 CapitalAlumni VenturesBuilders VCFundersClubHemisphere Ventures LLCLifeforce Capital+29 more
Ochre Bio develops RNA therapeutics and drug discovery platforms targeting liver disease, combining proprietary human liver datasets with AI-driven causal prediction and human tissue validation models.
AI & Machine LearningBiotechHealthtechMedical DevicesLondon, GB
Quin Wills(CSO)inJack O'Meara(Founder)in
BoardChinwe UkomaduElaine SullivanEliot ForsterJack Castle
Co-investorsBackedBeast VenturesCoastCapEntrepreneur FirstExpaHoxton Ventures+18 more
Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(President)inBagrat Grigoryan(COO)in
Co-investorsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude GomilaMethuselah Foundation+21 more
Exits · 3
2 IPOs · 1 acquisitions · showing 2Alto NeuroscienceNYSE: ANROVolumetricacq. by 3D Systems
Portfolio news
latest coverage across their companiesAspen Neuroscience · prnewswire.com · Nov 20, 2025
Frequently asked questions
- How many investments has Bioverge made?
- Bioverge has 8 tracked investments, 3 of which have exited.
- What stage does Bioverge invest at?
- Bioverge invests at the Seed stage.
- What sectors does Bioverge focus on?
- Bioverge focuses on Biotech, Healthtech.
- Where is Bioverge located?
- Bioverge is headquartered in San Francisco, US.
Media · Podcasts & interviews
featuring the teamAll About Transparent VC's with Neil Littman, Founder of Bioverge Ventures
CharmHealth · Neil Littman
Sergey Young, Longevity Vision Fund | Neil Littman, Bioverge | Longevity Investing
Foresight Institute · Neil Littman
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.